Induced sputum in adolescents with severe stable asthma. Safety and the relationship of cell counts and eosinophil cationic protein to clinical severity

European Respiratory Journal

Volumn 13, Issue 3, 1999, Pages 647-653

  Grootendorst, D C ^a,b   Van Den Bos, J W ^a   Romeijn, J J ^a   Veselic Charvat, M ^b   Duiverman, E J ^c   Vrijlandt, E J L E ^d   Sterk, P J ^b   Roldaan, A C ^a  

^a Dutch Asthma Centre   (Switzerland)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JULIANA CHILDREN S HOSPITAL   (Netherlands)

^d MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Asthma severity; Eosinophils; Sputum induction

Indexed keywords

ADENOSINE PHOSPHATE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE; HISTAMINE; SALBUTAMOL; STEROID;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CELL COUNT; CLINICAL ARTICLE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD; SCORING SYSTEM; SPIROMETRY; SPUTUM EXAMINATION;

EID: 0032961683     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.99.13364799     Document Type: Article

References (34)

1. Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434-457.
2. Poston RN, Chanez P, Lee TH, Lacoste JX Litchfield T, Bousquet J. Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis 1992; 145: 918-921.
3. Jeffery PK. Bronchial biopsies and airway inflammation. Eur Respir J 1996; 9: 1583-1587.
4. In't Veen JCCM, de Gouw HWFM, Smits HH, et al. Repeatability of cellular and soluble markers of inflammation in induced sputum from patients with asthma. Eur Respir J 1996; 9: 2441-2447.
5. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317.
6. Pin I, Gibson PG, Kolendowicz R, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25-29.
7. Fahy JV, Liu J, Wong H, Boushey HA. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993; 147: 1126-1131.
8. Gibson PG, Girgis-Gabardo A, Morris MM, et al. Cellular characteristics of sputum from patients with asthma and chronic bronchitis. Thorax 1989; 44: 693-699.
9. Fahy JV, Woo Kim K, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995; 95: 843-852.
10. Fahy JV, Liu J, Wong H, Boushey HA. Analysis of cellular and biochemical constituents of induced sputum after allergen challenge: a method for studying allergic airway inflammation. J Allergy Clin Immunol 1994; 93 1031-1039.
11. Pin I, Freitag AP, O'Byrne PM, et al. Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. Am Rev Respir Dis 1992; 145: 1265-1269.
12. Claman DM, Boushey HA, Liu J, Wong H, Fahy JV. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol 1994; 94: 861-869.
13. Jatakanon A, Lim S, O'Connor BJ, Chung KF, Barnes PJ. Inhaled budesonide improves non-invasive markers of airway inflammation in asymptomatic steroid naive asthmatic patients. Am J Respir Crit Care Med 1997; 155-A288.
14. Pizzichini E, Pizzichini MMM, Efthimiadis A, Dolovich J, Hargreave FE. Measuring airway inflammation in asthma: eosinophils and eosinophil cationic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol 1997; 99: 539-544.
15. Ronchi MC, Piragino C, Rosi E, Amendola M, Duranti R, Scano G. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax 1996; 51: 1000-1004.
16. Iredale MJ, Wanklyn SAR, Phillips IP, Krausz T, Ind PW. Non-invasive assessment of bronchial inflammation in asthma: no correlation between eosinophilia of induced sputum and bronchial responsiveness to inhaled hypertonic saline. Clin Exp Allergy 1994; 24: 940-945.
17. Grootendorst DC, Sont JK, Willems LNA, et al. Comparison of inflammatory cell counts in asthma: induced sputum versus bronchoalveolar lavage and bronchial biopsies. Clin Exp Allergy 1997; 27: 769-779.
18. Maestrelli P, Saetta M, Di Stefano A, et al. Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Am J Respir Crit Care Med 1995; 152: 1926-1931.
19. Pin I, Radford S, Kolendowicz R, et al. Airway inflammation in symptomatic and asymptomatic children with methacholine hyperresponsiveness. Eur Respir J 1993; 6: 1249-1256.
20. Twaddell SH, Gibson PG, Carty K, Woolley KL, Henry RL. Assessment of airway inflammation in children with acute asthma using induced sputum. Eur Respir J 1996; 9: 2104-2108.
21. Cockcroft DW, Swystun VA. Asthma control versus asthma severity. J Allergy Clin Immunol 1996; 98: 1016-1018.
22. National Heart Lung and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. NIH publication no. 97-4051. Bethesda, MD USA, 1997.
23. Quanjer PhH, Borsboom GJJM, Brunekreef B, et al. Spirometric reference values for white European children and adolescents: Polgar revisited. Pediatr Pulmonol 1995; 19: 135-142.
24. Quanjer PhH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yemault J-C. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6: Suppl. 16, 5-40.
25. Sterk PJ, Fabbri LM, Quanjer PhH, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993; 6: Suppl. 16, 53-83.
26. Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Rex 1996; 5: 35-46.
27. Oosterhoff Y, de Jong JW, Jansen MAM, Koeter GH, Postma DS. Airway responsiveness to adenosine 5′-monophosphate in chronic obstructive pulmonary disease is determined by smoking. Am Rev Respir Dis 1993; 147: 553-558.
28. Leigh TR, Nazir T, Wiggins J, Ganderton O, Collins JV. Performance characteristics of the DeVilbiss Ultraneb 99 ultrasonic nebuliser. Thorax 1990; 45: 817 (abstract).
29. Woolcock AJ, Jenkins CR. Assessment of bronchial responsiveness as a guide to prognosis and therapy in asthma. Med Clin N Am 1990; 74: 753-765.
30. Wong HA, Fahy JV. Safety of one method of sputum induction in asthmatic subjects. Am J Respir Crit Care Med 1997; 156: 299-303.
31. The British Thoracic Society, The National Asthma Campaign, The Royal College of Physicians of London in association with the General Practitioner in Asthma Group, the British Association of Accident and Emergency Medicine, the British Paediatric Respiratory Society and the Royal College of Paediatrics and Child Health. The British guidelines on asthma management 1995 review and position statement. Thorax 1997; 52 (Suppl. 1): S1-S21.
32. Phillips GD, Bagga PK, Djukanovic R, Holgate ST. The influence of refractoriness to adenosine 5′-monophosphate on allergen-provoked bronchoconstriction in asthma. Am Rev Respir Dis 1989; 140: 321-326.
33. Piacentini GL, Martinati L, Mingoni S, Boner AL. Influence of allergen avoidance on the eosinophil phase of airway inflammation in children with allergic asthma. J Allergy Clin Immunol 1996; 97: 1079-1084.
34. Liu H, Lazarus SC, Caughey G, Fahy JV. Neutrophil elastase degranulates eosinophils in vitro. Am J Respir Crit Care Med 1997; 155: A67.